Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Share-based Compensation (2021 - 2023)

Silo Pharma's Share-based Compensation history spans 4 years, with the latest figure at $47267.0 for Q3 2025.

  • For Q3 2025, Share-based Compensation changed N/A year-over-year to $47267.0; the TTM value through Sep 2025 reached $57155.0, changed N/A, while the annual FY2023 figure was $14125.0, 90.95% down from the prior year.
  • Share-based Compensation for Q3 2025 was $47267.0 at Silo Pharma, up from $1414.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $83728.0 in Q1 2021 and bottomed at $1414.0 in Q4 2023.
  • The 4-year median for Share-based Compensation is $25458.0 (2022), against an average of $30116.7.
  • The largest annual shift saw Share-based Compensation crashed 46.24% in 2022 before it plummeted 97.65% in 2023.
  • A 4-year view of Share-based Compensation shows it stood at $83728.0 in 2021, then decreased by 28.19% to $60122.0 in 2022, then tumbled by 97.65% to $1414.0 in 2023, then surged by 3242.79% to $47267.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Share-based Compensation are $47267.0 (Q3 2025), $1414.0 (Q4 2023), and $4237.0 (Q3 2023).